Alonimid

Alonimid

SCHEMBL114140

O=C1CCC2(CCC(=O)c3ccccc32)C(=O)N1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 10/20 0.38
BACE1 P56817 1/20 0.37
DDB1 Q16531 3/20 0.36
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
OPRL1 P41146 1/20 0.36
ITGA4 P13612 1/20 0.35
SRD5A1 P18405 1/20 0.35
MEN1 O00255 1/20 0.34
CYP2C9 P11712 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alonimid SCHEMBL29728701 1.00 CRBN (0.38) CRBNBACE1DDB1OPRM1OPRK1
SCHEMBL11844513 0.89 CRBN (0.40) CRBNBACE1DDB1OPRM1ITGA4
SCHEMBL11848256 0.89 BACE1 (0.36) CRBNBACE1DDB1ITGA4MEN1
Alonimid SCHEMBL8318670 0.83 PGR (0.34) CRBNOPRM1OPRK1OPRL1ITGA4
SCHEMBL11841796 0.78 PARP10 (0.39) CRBNDDB1
SCHEMBL11847241 0.78 SRD5A1 (0.43) CRBNSRD5A1
SCHEMBL11840949 0.78 CRBN (0.40) CRBNDDB1
SCHEMBL11069539 0.75 AKR1B1 (0.51)
SCHEMBL11841313 0.75 PDE3B (0.46)
SCHEMBL11843628 0.74 TDP2 (0.44) CRBNDDB1MEN1CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2385 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238250-A1 METHOD OF USING PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2024-07-18 US claimed
WO-2024150170-A1 PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2024-07-18 WO claimed
US-20190275048-A1 METHOD OF TREATING INSOMNIA ROSENBERG LEON I (US) 2019-09-12 US claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-8735383-B2 Glycine transporter-1 inhibitors AMGEN INC. (US) 2014-05-27 US claimed
US-8268352-B2 Modified release composition for highly soluble drugs TORRENT PHARMACEUTICALS LIMITED (IN) 2012-09-18 US claimed
US-8263125-B2 Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients TORRENT PHARMACEUTICALS LIMITED (IN) 2012-09-11 US claimed
US-20120195985-A1 GLYCINE TRANSPORTER-1 INHIBITORS AMGEN INC. (US) 2012-08-02 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
CN-101330905-A Freeze-drying process and products obtained thereby SCIDOSE LLC (US) 2008-12-24 CN claimed
US-20060018934-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
US-20060018933-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
EP-1599199-A2 METHODS FOR TREATING JOINT PAIN OR IMPROVING SLEEP USING AN ESTROGEN AGONIST/ANTAGONIST Pfizer Products Inc. (US) 2005-11-30 EP claimed
US-20040152713-A1 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist PFIZER INC. 2004-08-05 US claimed
WO-2004064832-A2 METHODS FOR TREATING JOINT PAIN OR IMPROVING SLEEP USING AN ESTROGEN AGONIST/ANTAGONIST PFIZER PRODUCTS INC. (US) 2004-08-05 WO claimed
JP-2000511885-A 2000-09-12 JP claimed
EP-0900086-A4 ENHANCEMENT OF SLEEP WITH A GROWTH HORMONE SECRETAGOGUE MERCK & CO INC (US) 2000-01-12 EP claimed
EP-0900086-A1 ENHANCEMENT OF SLEEP WITH A GROWTH HORMONE SECRETAGOGUE Merck & Co., Inc. (US) 1999-03-10 EP claimed
WO-1997041879-A1 ENHANCEMENT OF SLEEP WITH A GROWTH HORMONE SECRETAGOGUE MERCK & CO., INC. (US) 1997-11-13 WO claimed
US-3985888-A Methods of inducing sedation using certain spiroalkanone-imides RICHARDSON-MERRELL INC. (US) 1976-10-12 US claimed